Cargando…
Glycosylation alterations in serum of Alzheimer's disease patients show widespread changes in N‐glycosylation of proteins related to immune function, inflammation, and lipoprotein metabolism
INTRODUCTION: There is an increased need for the development of novel blood‐based biomarkers for early detection, prevention, or intervention in Alzheimer's disease (AD). This study sought to determine whether serum glycopeptide analysis holds potential for identifying novel diagnostics and pro...
Autores principales: | Tena, Jennyfer, Tang, Xinyu, Zhou, Qingwen, Harvey, Danielle, Barajas‐Mendoza, Maria, Jin, Lee‐Way, Maezawa, Izumi, Zivkovic, Angela M., Lebrilla, Carlito B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043904/ https://www.ncbi.nlm.nih.gov/pubmed/35496372 http://dx.doi.org/10.1002/dad2.12309 |
Ejemplares similares
-
Transcriptomic and glycomic analyses highlight pathway-specific glycosylation alterations unique to Alzheimer’s disease
por: Tang, Xinyu, et al.
Publicado: (2023) -
N-Glycomic Analysis of the Cell Shows Specific Effects of Glycosyl Transferase Inhibitors
por: Zhou, Qingwen, et al.
Publicado: (2021) -
Regio-Specific N-Glycome and N-Glycoproteome Map of the Elderly Human Brain With and Without Alzheimer’s Disease
por: Tena, Jennyfer, et al.
Publicado: (2022) -
High-Density Lipoprotein Changes in Alzheimer’s Disease Are APOE Genotype-Specific
por: Hong, Brian V., et al.
Publicado: (2022) -
Quantitative glycoproteomics of high-density lipoproteins
por: Tang, Xinyu, et al.
Publicado: (2022)